Login / Signup

Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.

Marco ValgimigliAdrian WlodarczakRalph TölgBela MerkelyHenning KelbækEwa Ł StępieńStefano GalliMatthieu GodinGabor G TothThibault LhermusierBenjamin HontonPeter Laurenz DietrichFrancis StammenBert FerdinandeJohanne SilvainDavide CapodannoGuillaume Caylanull null
Published in: Circulation (2023)
Keyphrases
  • open label
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • drug delivery
  • phase ii study
  • randomized controlled trial
  • squamous cell carcinoma